GLP-1 Medicines and Fatty Liver: Can Semaglutide or Tirzepatide Help MASLD? | Dr. Moxit Shah, DM Endocrinologist in Ahmedabad
Introduction Fatty liver is becoming increasingly common, particularly among people with overweight, obesity, insulin resistance and type 2 diabetes. The condition is now commonly referred to as metabolic dysfunction-associated steatotic liver disease (MASLD). Many people with fatty liver have no symptoms and discover it incidentally during an ultrasound or blood test. This often leads to…
